224 related articles for article (PubMed ID: 12901348)
1. Critical review of pathogenetic mechanisms in myelofibrosis with myeloid metaplasia.
Martyré MC
Curr Hematol Rep; 2003 May; 2(3):257-63. PubMed ID: 12901348
[TBL] [Abstract][Full Text] [Related]
2. Stem cell dysregulation in myelofibrosis with myeloid metaplasia: current data on growth factor and transcription factor involvement.
Martyré MC; Le Bousse-Kerdilès MC;
Semin Oncol; 2005 Aug; 32(4):373-9. PubMed ID: 16202683
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
4. Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.
Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A
Best Pract Res Clin Haematol; 2006; 19(3):495-517. PubMed ID: 16781486
[TBL] [Abstract][Full Text] [Related]
5. RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia.
Jones LC; Tefferi A; Idos GE; Kumagai T; Hofmann WK; Koeffler HP
Oncogene; 2004 Oct; 23(47):7846-53. PubMed ID: 15361842
[TBL] [Abstract][Full Text] [Related]
6. New approaches in the treatment of myelofibrosis.
Hennessy BT; Thomas DA; Giles FJ; Kantarjian H; Verstovsek S
Cancer; 2005 Jan; 103(1):32-43. PubMed ID: 15565565
[TBL] [Abstract][Full Text] [Related]
7. Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case.
Gerli GC; Gianelli U; Carraro MC; Bestetti A; Marchetti M; Barosi G
Haematologica; 2001 Aug; 86(8):885-6. PubMed ID: 11524257
[No Abstract] [Full Text] [Related]
8. [Agnogenic myeloid metaplasia. Etiology and pathogenesis].
Gutiérrez Martín M; Gómez Casal F
Rev Clin Esp; 1983 Apr; 169(2):77-82. PubMed ID: 6348893
[No Abstract] [Full Text] [Related]
9. [Idiopathic myelofibrosis. Main pathogenetic, prognostic and therapeutic aspects].
Barulli S; Rupoli S; Cinciripini A; Scortechini AR; Cantori I; Leoni P
Recenti Prog Med; 1995; 86(7-8):312-9. PubMed ID: 7569290
[TBL] [Abstract][Full Text] [Related]
10. New insights into the pathogenesis and drug treatment of myelofibrosis.
Tefferi A
Curr Opin Hematol; 2006 Mar; 13(2):87-92. PubMed ID: 16456374
[TBL] [Abstract][Full Text] [Related]
11. Current perspective in agnogenic myeloid metaplasia.
Tefferi A; Silverstein MN
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():169-71. PubMed ID: 8951788
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
Chagraoui H; Wendling F; Vainchenker W
Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
[TBL] [Abstract][Full Text] [Related]
13. Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?
Hasselbalch HC
Leuk Res; 2009 Jan; 33(1):11-8. PubMed ID: 18632152
[TBL] [Abstract][Full Text] [Related]
14. Agnogenic myelofibrosis in children--a case report and review of the literature.
Hamazaki M; Mugishima H
Acta Pathol Jpn; 1981 Jan; 31(1):143-52. PubMed ID: 7234418
[TBL] [Abstract][Full Text] [Related]
15. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
Piaserico PL; Piaserico GP
Minerva Med; 1983 Oct; 74(39):2313-8. PubMed ID: 6657100
[TBL] [Abstract][Full Text] [Related]
16. A review of myelofibrosis in dogs.
Reagan WJ
Toxicol Pathol; 1993; 21(2):164-9. PubMed ID: 8210938
[TBL] [Abstract][Full Text] [Related]
17. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia.
Reilly JT
Semin Oncol; 2005 Aug; 32(4):359-64. PubMed ID: 16202681
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of myelofibrosis with myeloid metaplasia: lessons from mouse models of the disease.
Vannucchi AM; Migliaccio AR; Paoletti F; Chagraoui H; Wendling F
Semin Oncol; 2005 Aug; 32(4):365-72. PubMed ID: 16202682
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic myelofibrosis with extramedullary hematopoiesis in the kidneys.
Schnuelle P; Waldherr R; Lehmann KJ; Woenckhaus J; Back W; Niemir Z; van der Woude FJ
Clin Nephrol; 1999 Oct; 52(4):256-62. PubMed ID: 10543329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
